Warberg Asset Management LLC Lixte Biotechnology Holdings, Inc. Transaction History

Warberg Asset Management LLC

  • $21.3 Million
  • Q2 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022
BUY
$0.12 - $0.35 $1,740 - $5,075
14,500 New
14,500 $11,000

About LIXTE BIOTECHNOLOGY HOLDINGS, INC.

LIXT Quotes by TradingView
  • Ticker LIXT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,646,600
  • Market Cap $33.6M
  • Description
  • Lixte Biotechnology Holdings, Inc. operates as a drug discovery company that uses biomarker technology to identify enzyme targets related with serious common diseases and designs novel compounds to attack those targets. The company primarily focuses on inhibitors of protein phosphatases that are used alone and in combination with cytotoxic agent...
More about LIXT
Track This Portfolio

Track Warberg Asset Management LLC Portfolio

Follow Warberg Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Warberg Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Warberg Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email